Find clinical trials for Endometrial Cancer in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near New Haven, CT, USA:
The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial...
Phase 2
New Haven, Connecticut, United States
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
New Haven, Connecticut, United States and 28 other locations
This study will test whether the combination of radiation and Dostarlimab is an effective treatment for women with MMR-D/MSI-H endometrial c...
Phase 2
Commack, New York, United States and 6 other locations
Primary Objectives: To assess the antitumor activity (proportion of objective response by RECIST 1.1 criteria) of pembrolizumab with objective tumor...
Phase 2
New Haven, Connecticut, United States
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
New Haven, Connecticut, United States and 223 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
West Islip, New York, United States and 82 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
New Haven, Connecticut, United States and 35 other locations
is an effective treatment for people with persistent or recurrent endometrial cancer or endometrial carcinosarcoma. The re...
Phase 2
Commack, New York, United States and 6 other locations
drug BMS-986205. Adding BMS-986208 to nivolumab could shrink the cancer or prevent it from returning, but it could also cause side effects....
Phase 2
Commack, New York, United States and 6 other locations
Uterine serous carcinoma (USC) accounts for up to 40% of endometrial cancer-related deaths. Patients with USC share many genomic an...
Phase 2
Greenlawn, New York, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal